JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M203953200 on September 19, 2002

J. Biol. Chem., Vol. 277, Issue 47, 44996-45003, November 22, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/47/44996    most recent
M203953200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiang, X.
Right arrow Articles by Luo, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiang, X.
Right arrow Articles by Luo, Z.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphorylation of 338SSYY341 Regulates Specific Interaction between Raf-1 and MEK1*

Xiaoqin XiangDagger , Mengwei ZangDagger , Christine A. WaeldeDagger , Rong Wen§, and Zhijun LuoDagger ||

From the Dagger  Diabetes and Metabolism Research Unit, Endocrinology Section, Evans Department of Medicine and the  Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts 02118 and the § Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

The present study characterizes the interaction between the Raf-1 kinase domain and MEK1 and examines whether the magnitude of their interaction correlates to the ability of Raf to phosphorylate MEK1. Here we show that the minimal domain required for the Raf kinase activity starts from tryptophan 342. Maximal binding of the Raf kinase domain to MEK1 and its kinase activity are achieved upon phosphorylation of the region 338SSYY341 in response to 4beta -12-O-tetradecanoylphorbol-13-acetate (TPA), or mutation of Y340Y341 to aspartic acids. Conversely, the TPA-stimulated MEK binding and kinase activity are diminished when this region is deleted or Ser338 and Ser339 are mutated to alanines. We also show that the integrity of the Raf ATP-binding site is necessary for the interaction between Raf-1 and MEK1. Furthermore, two MEK-binding sites are identified; the first is localized between amino acids 325 and 349, and the second is within the region between amino acids 350 and 648. Separately, the binding of each site to MEK1 is weak, but in a cis context, they give rise to a much stronger association, which can be further stimulated by TPA. Finally, we find that tryptophan 342, which is conserved among the Raf family and other protein kinases, is essential for the Ser338 phosphorylation of the full-length Raf and its binding to MEK1. Taken together, our results indicate that the phosphorylation of Ser338 and Tyr341 on Raf exerts an important effect on reconfiguring the two MEK-binding sites. As a result, these two sites coordinate to form a high affinity MEK-binding epitope, leading to a marked increase in Raf kinase activity.


* This work was supported by National Institutes of Health Grant GM 57959 (to Z. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Diabetes and Metabolism Research Unit, Boston University School of Medicine, 650 Albany St., Rm. 820, Boston, MA 02118. Tel.: 617-414-1033; Fax: 617-638-7094; E-mail: zluo@medicine.bu.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Gorelik, J. Y. Fang, A. Wu, A. H. Sawalha, and B. Richardson
Impaired T Cell Protein Kinase C{delta} Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus
J. Immunol., October 15, 2007; 179(8): 5553 - 5563.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Feng, X. Xie, Q. Ding, X. Luo, J. He, F. Fan, W. Liu, Z. Wang, and Y. Chen
Spatial regulation of Raf kinase signaling by RKTG
PNAS, September 4, 2007; 104(36): 14348 - 14353.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Zhang, Z. Li, X. Wu, Q. Huang, H.-M. Shen, and C.-N. Ong
Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway
Mol. Cancer Ther., December 1, 2006; 5(12): 3285 - 3293.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. L. Edin and R. L. Juliano
Raf-1 Serine 338 Phosphorylation Plays a Key Role in Adhesion-Dependent Activation of Extracellular Signal-Regulated Kinase by Epidermal Growth Factor
Mol. Cell. Biol., June 1, 2005; 25(11): 4466 - 4475.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tsukamoto, A. Irie, and Y. Nishimura
B-Raf Contributes to Sustained Extracellular Signal-regulated Kinase Activation Associated with Interleukin-2 Production Stimulated through the T Cell Receptor
J. Biol. Chem., November 12, 2004; 279(46): 48457 - 48465.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Chen and A. J. Sytkowski
Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism
Blood, July 1, 2004; 104(1): 73 - 80.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. H. Tran and J. A. Frost
Phosphorylation of Raf-1 by p21-activated Kinase 1 and Src Regulates Raf-1 Autoinhibition
J. Biol. Chem., March 21, 2003; 278(13): 11221 - 11226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.